Nicotine induces chromatin remodelling through decreases in the methyltransferases GLP, G9a, Setdb1 and levels of H3K9me2

International Journal of Neuropsychopharmacology

Volumn 16, Issue 5, 2013, Pages 1129-1138

  Chase, Kayla A ^a   Sharma, Rajiv P ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Epigenetics; H3K9me2; histone; nicotine; schizophrenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; HISTONE H3; HISTONE METHYLTRANSFERASE; MESSENGER RNA; NICOTINE; PROTEIN G9A; PROTEIN GLP; PROTEIN SETDB1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; LYMPHOCYTES; MALE; MICE; MICE, INBRED ICR; NEURONS; NICOTINE; NICOTINIC AGONISTS;

EID: 84877979055     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145712001101     Document Type: Article

References (71)

1. Aid T, Kazantseva A, Piirsoo M, Palm K, et al. (2007). Mouse and rat BDNF gene structure and expression revisited. Journal of Neuroscience Research 3, 525-535.
2. Bach MA, Bach JF (1972). Activities of immunosuppressive agents in vitro. II. Different timing of azathioprine and methotrexate in inhibition and stimulation of mixed lymphocyte reaction. Clinical and Experimental Immunology 1, 89-98.
3. Barik J, Wonnacott S (2009). Molecular and cellular mechanisms of action of nicotine in the CNS. Handbook of Experimental Pharmacology 192, 173-207.
4. Benhammou K, Lee M, Strook M, Sullivan B, et al. (2000). (3)H]Nicotine binding in peripheral blood cells of smokers is correlated with the number of cigarettes smoked per day. Neuropharmacology 13, 2818-2829.
5. Bobes J, Arango C, Garcia-Garcia M, Rejas J (2010). Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophrenia Research 1-3, 101-109.
6. Bose C, Zhang H, Udupa KB, Chowdhury P (2005). Activation of p-ERK1/2 by nicotine in pancreatic tumor cell line AR42J: effects on proliferation and secretion. American Journal of Physiology 5, G926-G934.
7. Burli T, Baer K, Ewers H, Sidler C, et al. (2010). Single particle tracking of alpha7 nicotinic AChR in hippocampal neurons reveals regulated confinement at glutamatergic and GABAergic perisynaptic sites. PloS One 7, e11507.
8. Calabresi P, Lacey MG, North RA (1989). Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording. British Journal of Pharmacology 1, 135-140.
9. Cattaneo MG, Codignola A, Vicentini LM, Clementi F, Sher E (1993). Nicotine stimulates a serotonergic autocrine loop in human small-cell lung carcinoma. Cancer Research 22, 5566-5568.
10. Chen WG, West AE, Tao X, Corfas G, et al. (2003). Upstream stimulatory factors are mediators of Ca2+-responsive transcription in neurons. Journal of Neuroscience 7, 2572-2581.
11. Choi DW, Maulucci-Gedde M, Kriegstein AR (1987). Glutamate neurotoxicity in cortical cell culture. Journal of Neuroscience 2, 357-368.
12. Dani JA, de Biasi M (2001). Cellular mechanisms of nicotine addiction. Pharmacology, Biochemistry, and Behavior 4, 439-446.
13. Dawson VL, Dawson TM, London ED, Bredt DS, et al. (1991). Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proceedings of the National Academy of Sciences USA 14, 6368-6371.
14. De Rosa MJ, Esandi Mdel C, Garelli A, Rayes D, et al. (2005). Relationship between alpha 7 nAChR and apoptosis in human lymphocytes. Journal of Neuroimmunology 1-2, 154-161.
15. Fang MA, Frost PJ, Iida-Klein A, Hahn TJ (1991). Effects of nicotine on cellular function in UMR 106-01 osteoblast-like cells. Bone 4, 283-286.
16. Fox JH, Barber DS, Singh B, Zucker B, et al. (2004). Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation. Journal of Neurochemistry 2, 413-422.
17. Fujii T, Takada-Takatori Y, Kawashima K (2008). Basic and clinical aspects of non-neuronal acetylcholine: expression of an independent, non-neuronal cholinergic system in lymphocytes and its clinical significance in immunotherapy. Journal of Pharmacological Sciences 2, 186-192.
18. Gavin DP, Kartan S, Chase K, Grayson DR, et al. (2008). Reduced baseline acetylated histone 3 levels, and a blunted response to HDAC inhibition in lymphocyte cultures from schizophrenia subjects. Schizophrenia Research 1-3, 330-332.
19. Gavin DP, Kartan S, Chase K, Jayaraman S, et al. (2009a). Histone deacetylase inhibitors and candidate gene expression: an in vivo and in vitro approach to studying chromatin remodeling in a clinical population. Journal of Psychiatric Research 9, 870-876.
20. Gavin DP, Rosen C, Chase K, Grayson DR, et al. (2009b). Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures. Journal of Psychiatry and Neuroscience 3, 232-237.
21. Gavin DP, Sharma RP (2009). Chromatin from peripheral blood mononuclear cells as biomarkers for epigenetic abnormalities in schizophrenia. Cardiovascular Psychiatry and Neurology. Published online: 22 July 2009. doi:10.1155/2009/409562.
22. Gavin DP, Sharma RP, Chase KA, Matrisciano F, et al. (2012). Growth arrest and DNA-damage-inducible, beta (GADD45b)-mediated DNA demethylation in major psychosis. Neuropsychopharmacology 372, 531-42.
23. Gavin 3rd JR, Roth J, Neville Jr. DM, de Meyts P, et al. (1974). Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. Proceedings of the National Academy of Sciences USA 1, 84-88.
24. Gupta S, Kim SY, Artis S, Molfese DL, et al. (2010). Histone methylation regulates memory formation. Journal of Neuroscience 10, 3589-3599.
25. Haring M, Offermann S, Danker T, Horst I, et al. (2007). Chromatin immunoprecipitation: optimization, quantitative analysis and data normalization. Plant Methods 3, 11.
26. Hiemke C, Stolp M, Reuss S, Wevers A, et al. (1996). Expression of alpha subunit genes of nicotinic acetylcholine receptors in human lymphocytes. Neuroscience Letters 2-3, 171-174.
27. Issidorides MR, Stefanis CN, Varsou E, Katsorchis T (1975). Altered chromatin ultrastructure in neutrophils of schizophrenics. Nature 5536, 612-614.
28. Jayaraman S, Castro M, O'Sullivan M, Bragdon MJ, et al. (1999). Resistance to Fas-mediated T cell apoptosis in asthma. Journal of Immunology (Baltimore, MD) 3, 1717-1722.
29. Jenuwein T (2001). Re-SET-ting heterochromatin by histone methyltransferases. Trends in Cell Biology 6, 266-273.
30. Kenny PJ, File SE, Rattray M (2000). Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Brain Research Molecular Brain Research 1-2, 234-238.
31. Koppel I, Aid-Pavlidis T, Jaanson K, Sepp M, et al. (2009). Tissue-specific and neural activity-regulated expression of human BDNF gene in BAC transgenic mice. BMC Neuroscience 10, 68.
32. Kramer JM, Kochinke K, Oortveld MA, Marks H, et al. (2011). Epigenetic regulation of learning and memory by Drosophila EHMT/G9a. PLoS Biology 1, e1000569.
33. Landais E, El-Khoury V, Prevost A, Dufer J, et al. (2005). Nicotine induces chromatin changes and c-Jun up-regulation in HL-60 leukemia cells. Oncology Reports 6, 1553-1558.
34. Levine A, Huang Y, Drisaldi B, Griffin Jr. EA, et al. (2011). Molecular mechanism for a gateway drug: epigenetic changes initiated by nicotine prime gene expression by cocaine. Science Translational Medicine 107, 107-109.
35. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (San Diego, CA) 4, 402-408.
36. Lohr JB, Flynn K (1992). Smoking and schizophrenia. Schizophrenia Research 2, 93-102.
37. McClave AK, McKnight-Eily LR, Davis SP, Dube SR (2010). Smoking characteristics of adults with selected lifetime mental illnesses: results from the 2007 National Health Interview Survey. American Journal of Public Health 12, 2464-2472.
38. Mannhalter C, Koizar D, Mitterbauer G (2000). Evaluation of RNA isolation methods and reference genes for RT-PCR analyses of rare target RNA. Clinical Chemistry and Laboratory Medicine 2, 171-177.
39. Maze I, Covington 3rd HE, Dietz DM, LaPlant Q, et al. (2010). Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science (New York) 5962, 213-216.
40. Miao F, Chen Z, Zhang L, Liu Z, et al. (2012). Profiles of epigenetic histone post-translational modifications at type 1 diabetes susceptible genes. Journal of Biological Chemistry 287, 16335-16345.
41. Miao F, Smith DD, Zhang L, Min A, et al. (2008). Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes. Diabetes 57, 3189-3198.
42. 2+ in isolated bovine adrenal medullary cells. Effects of TMB-8 and phorbol ester TPA. FEBS Letters 1, 25-28.
43. Nelson JD, Denisenko O, Bomsztyk K (2006). Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nature Protocols 1, 179-185.
44. Nillesen WM, Yntema HG, Moscarda M, Verbeek NE, et al. (2011). Characterization of a novel transcript of the EHMT1 gene reveals important diagnostic implications for Kleefstra syndrome. Human Mutation 7, 853-859.
45. Noh JS, Gwag BJ (1997). Attenuation of oxidative neuronal necrosis by a dopamine D1 agonist in mouse cortical cell cultures. Experimental Neurology 2, 604-608.
46. Noh JS, Sharma RP, Veldic M, Salvacion AA, et al. (2005). DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures. Proceedings of the National Academy of Sciences USA 5, 1749-1754.
47. Oberdoerffer P, Sinclair DA (2007). The role of nuclear architecture in genomic instability and ageing. Nature Reviews Molecular Cell Biology 9, 692-702.
48. Pruunsild P, Kazantseva A, Aid T, Palm K, et al. (2007). Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics 3, 397-406.
49. Pruunsild P, Sepp M, Orav E, Koppel I, et al. (2011). Identification of cis-elements and transcription factors regulating neuronal activity-dependent transcription of human BDNF gene. Journal of Neuroscience 9, 3295-3308.
50. Ryu H, Lee J, Hagerty SW, Soh BY, et al. (2006). ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease. Proceedings of the National Academy of Sciences USA 50, 19176-19181.
51. Sagud M, Mihaljevic-Peles A, Muck-Seler D, Pivac N, et al. (2009). Smoking and schizophrenia. Psychiatria Danubina 3, 371-375.
52. Sato KZ, Fujii T, Watanabe Y, Yamada S, et al. (1999). Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines. Neuroscience Letters 1, 17-20.
53. Satta R, Maloku E, Zhubi A, Pibiri F, et al. (2008). Nicotine decreases DNA methyltransferase 1 expression and glutamic acid decarboxylase 67 promoter methylation in GABAergic interneurons. Proceedings of the National Academy of Sciences USA 42, 16356-16361.
54. Schaefer A, Sampath SC, Intrator A, Min A, et al. (2009). Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor complex. Neuron 5, 678-691.
55. Schmittgen TD, Livak KJ (2008). Analyzing real-time PCR data by the comparative C(T) method. Nature Protocols 6, 1101-1108.
56. Schreiber R, Dalmus M, De Vry J (2002). Effects of alpha 4/beta 2-and alpha 7-nicotine acetylcholine receptor agonists on prepulse inhibition of the acoustic startle response in rats and mice. Psychopharmacology 3, 248-257.
57. Sharma RP, Gavin DP, Chase KA (2012). Heterochromatin as an incubator for pathology and treatment non-response: implication for neuropsychiatric illness. Pharmacogenomics Journal. Published online: 17 February 2012. doi:10.1038/tpj.2011.64.
58. Sharma RP, Grayson DR, Gavin DP (2008). Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection. Schizophrenia Research 1-3, 111-117.
59. Shinkai Y, Tachibana M (2011). H3K9 methyltransferase G9a and the related molecule GLP. Genes and Development 8, 781-788.
60. Simonini MV, Camargo LM, Dong E, Maloku E, et al. (2006). The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases. Proceedings of the National Academy of Sciences USA 5, 1587-1592.
61. Sims 3rd RJ, Nishioka K, Reinberg D (2003). Histone lysine methylation: a signature for chromatin function. Trends in Genetics 11, 629-639.
62. Son JH, Winzer-Serhan UH (2009). Chronic neonatal nicotine exposure increases mRNA expression of neurotrophic factors in the postnatal rat hippocampus. Brain Research 1278, 1-14.
63. Stefanis CN, Issidorides MR (1976). Histochemical changes in the blood cells of schizophrenic patients under pimozide treatment. Biological Psychiatry 1, 53-68.
64. Stolerman IP, Fink R, Jarvik ME (1973). Acute and chronic tolerance to nicotine measured by activity in rats. Psychopharmacologia 4, 329-342.
65. Tachibana M, Ueda J, Fukuda M, Takeda N, et al. (2005). Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes and Development 7, 815-826.
66. Terranova R, Agherbi H, Boned A, Meresse S, Djabali M (2006). Histone and DNA methylation defects at Hox genes in mice expressing a SET domain-truncated form of Mll. Proceedings of the National Academy of Sciences USA, 103, 6629-6634.
67. Timmusk T, Palm K, Metsis M, Reintam T, et al. (1993). Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 3, 475-489.
68. Tsankova NM, Kumar A, Nestler EJ (2004). Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures. Journal of Neuroscience 24, 5603-5610.
69. Tzeng TY, Lee CH, Chan LW, Shen CK (2007). Epigenetic regulation of the Drosophila chromosome 4 by the histone H3K9 methyltransferase dSETDB1. Proceedings of the National Academy of Sciences USA 31, 12691-12696.
70. Volkel P, Angrand PO (2007). The control of histone lysine methylation in epigenetic regulation. Biochimie 1, 1-20.
71. Wonnacott S, Sidhpura N, Balfour DJ (2005). Nicotine: from molecular mechanisms to behaviour. Current Opinion in Pharmacology 1, 53-59.